Interactive, Live Webinar

Wednesday, May 15, 2024

1:00 PM - 2:00 PM ET 
 

Target Audience

This activity is intended for hematologist/oncologists, oncology nurses, physician assistants, social workers, and other healthcare professionals involved in the care of patients with myeloproliferative neoplasms (MPNs).

 

    Educational Objectives

    After completing this activity, the participant should be better able to:

    • Provide an overview of MPNs

    • Apply diagnostic criteria for a correct diagnosis and grade

    • Explain low risk symptomatic myelofibrosis, intermediate, and high-risk primary or secondary, including genetic mutations, and risk stratification

    • Apply data on approved treatments and clinical trials into clinical practice

    • Implement strategies across the care team to educate and support patients

    Speakers

    Kathryn Johnson, DNP, MSc, FNP-BC
    Clinical Program Manager
    Tisch Cancer Institute
    Icahn School of Medicine at Mount Sinai
    New York, NY
     
    John Mascarenhas, MD
    Director, Center of Excellence in Blood Cancers and Myeloid Disorders
    Director, Adult Leukemia Program
    Leader, Myeloproliferative Disorders Clinical Research Program
    Tisch Cancer Institute, Division of Hematology/Oncology
    Professor of Medicine
    Icahn School of Medicine at Mount Sinai
    New York, NY
     
     
     
     
     

    This activity is jointly provided by The Leukemia & Lymphoma Society and Postgraduate Institute for Medicine.

    There is no commercial support associated with this CE activity.

     

    For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.

    Follow LLS